Introduction
The Biosurgery Market size is estimated at USD 16.89 billion in 2025, and is expected to reach USD 23.72 billion by 2030, at a CAGR of 7.03% during the forecast period (2025-2030). This growth reflects a steady climb in demand for biosurgical solutions as hospitals worldwide adopt advanced wound closure, hemostasis, and tissue repair technologies. The rise in surgical complexity, increasing geriatric population requiring orthopedic and cardiovascular interventions, and growing preference for minimally invasive surgeries are contributing strongly to market expansion. The market’s upward trajectory highlights an increasing emphasis on faster recoveries, reduced hospital stays, and improved post-surgical outcomes, creating robust demand for next-generation biomaterials and biosurgical systems.
Key Trends
Increasing Adoption of Minimally Invasive and Robotic-Assisted Surgeries
One of the most significant trends shaping the biosurgery market is the increasing shift toward minimally invasive procedures (MIS), including laparoscopic and robotic-assisted surgeries. These procedures lead to smaller incisions, less blood loss, shorter hospital stays, and quicker recovery times benefits that make biosurgery products such as absorbable hemostats, sealants, adhesives, and anti-adhesion barriers essential. As more surgeons and healthcare facilities invest in MIS capabilities, the demand for biosurgical products compatible with these techniques is growing.
Advances in Biomaterials and Biocompatible Solutions
Another clear trend is the increasing use of advanced biomaterials both biologic and synthetic that improve tissue repair, minimize immune response, and support faster healing. Biologic products such as fibrin and collagen matrices remain dominant, but synthetic and semi-synthetic materials are rapidly gaining ground due to improved shelf life, lower logistical constraints, and lower dependency on cold-chain storage.
Growing Demand from Orthopedic and Cardiovascular Surgeries
The increasing volume of orthopedic surgeries including joint replacements, bone repair, and sports-medicine procedures is driving demand for bone graft substitutes, hemostatic agents, and soft tissue repair solutions. In 2024, orthopedic surgery contributed a significant share of the biosurgery market.
Shift Toward Ambulatory and Outpatient Surgical Settings
Hospitals remain the primary end-user of biosurgical products, but ambulatory surgical centers (ASCs) are emerging as a significant growth area. As healthcare systems across the world emphasize cost efficiency and shorter patient stays, outpatient procedures are becoming more common. This shift increases demand for biosurgery solutions designed for quick application, portability, and compatibility with outpatient workflows.
Market Segmentation
The global biosurgery market can be segmented across several dimensions, including product type, source (material), application, and end user. Key segments include:
By Product Type
- Bone-Graft Substitutes
- Hemostatic Agents
- Surgical Sealants & Adhesives
- Adhesion Barriers
- Soft-Tissue Attachments
- Staple-Line Reinforcement
By Source
- Biologic
- Synthetic / Semi-synthetic
By Application
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Gynecological Surgery
- Thoracic & Reconstructive Surgery
By End User
- Hospitals
- Ambulatory Surgical Centres
- Specialty Clinics
By Geography
- North America
- Europe
- Asia-Pacific
- Middle East & Africa
- South America
Key Players
The biosurgery market features several established multinational firms that offer a wide range of biosurgical products and have extensive global distribution networks. These companies benefit from scale, regulatory experience, and large portfolios spanning bone graft substitutes, sealants, adhesives, and tissue repair products.
- Baxter International Inc.
- Johnson & Johnson
- Becton, Dickinson and Company
- B. Braun Melsungen AG
- CryoLife (Artivion)
The competitive landscape remains moderately crowded, yet continues evolving as new entrants bring niche solutions and focused biomaterials to surgeons and healthcare providers seeking better healing outcomes and cost-effective care.
Conclusion
The biosurgery market is on a solid upward trajectory from 2025 through 2030, as projected by market analysts. The combined impact of increasing surgical volumes especially in orthopedics and cardiovascular surgery the shift toward minimally invasive and robotic-assisted procedures, and advances in biomaterials are all contributing to this growth.
With bone-graft substitutes and biologic materials currently leading market share, and surgical sealants, adhesives, and synthetic biomaterials gaining momentum, the biosurgery market is diversifying. Demand is rising not only in large hospital settings but also in ambulatory surgical centers and outpatient clinics, reflecting changing healthcare delivery models.
Industry related Reports:
Spinal Surgery Market: The Spinal Surgery Market is Segmented by Device Type (Spinal Decompression Devices, and More), Procedure Type (Open Spine Surgery, and Minimally Invasive Spine Surgery), Surgical Technology (Robotic-Assisted Systems, and More), Surgery Setting (Hospitals, and More), Services (Intraoperative Neuromonitoring Services, and More), and Geography (North America, and More).
Dental Diagnostic And Surgical Market: The Dental Diagnostic and Surgical Market is Segmented by Type of Equipment (Dental Systems and Equipment, Dental Lasers, Dental Radiology Equipment, and More), Treatment (Orthodontic, Endodontic, Periodontic, and Prosthodontic), End User (Hospitals, Dental Clinics and More), and Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa).
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/